PD-1 Combined With Intensity Modulated Radiation Therapy in the Treatment of Intermediate-risk Nasopharyngeal Carcinoma

Clinical trial NCT05229315 · UNKNOWN

Trial details

NCT number: NCT05229315
Sponsor: XIANG YANQUN
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Nasopharyngeal Carcinoma T2-3N0 or T1-2N1 EBV-DNA≤4000 Copy/ml

Start date: 2022-03-12
Primary completion: 2023-12-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.